Compare KALA & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KALA | FHB |
|---|---|---|
| Founded | 2009 | 1858 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.1M | 3.3B |
| IPO Year | 2017 | 2016 |
| Metric | KALA | FHB |
|---|---|---|
| Price | $0.41 | $26.26 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 6 |
| Target Price | ★ $31.50 | $27.50 |
| AVG Volume (30 Days) | 930.0K | ★ 1.7M |
| Earning Date | 03-30-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 3.99% |
| EPS Growth | N/A | ★ 22.91 |
| EPS | N/A | ★ 2.20 |
| Revenue | N/A | ★ $853,588,000.00 |
| Revenue This Year | N/A | $6.97 |
| Revenue Next Year | N/A | $3.70 |
| P/E Ratio | ★ N/A | $11.86 |
| Revenue Growth | N/A | ★ 7.53 |
| 52 Week Low | $0.36 | $20.32 |
| 52 Week High | $20.60 | $28.35 |
| Indicator | KALA | FHB |
|---|---|---|
| Relative Strength Index (RSI) | 32.78 | 40.01 |
| Support Level | $0.36 | $26.54 |
| Resistance Level | $0.46 | $27.42 |
| Average True Range (ATR) | 0.05 | 0.81 |
| MACD | -0.01 | -0.17 |
| Stochastic Oscillator | 9.15 | 0.60 |
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.